A Rare Immune Deficiency Linked to Severe Type 1 Diabetes: What One Case Reveals

Type 1 diabetes usually develops when the immune system mistakenly attacks the insulin-producing cells in the pancreas. But a newly documented case reveals a different path: a genetic defect in a protein called CD70 led to severe type 1 diabetes in a patient.

CD70 is a protein that plays a role in how immune cells communicate and function. Deficiency in CD70 has been known to cause immune dysregulation and other serious conditions, but this is the first time researchers have documented it causing type 1 diabetes in a human. Animal studies had hinted at this connection, but the human case was previously unknown.

The patient experienced unusually severe type 1 diabetes, presenting with severe diabetic ketoacidosis—a life-threatening condition where the body produces too many acids—along with dysfunction in multiple organs. Beyond the severe diabetes, the clinical picture included recurrent episodes of diabetic ketoacidosis, unexplained skin lesions, and celiac disease, which puzzled doctors.

These atypical features prompted a deeper investigation. Doctors used advanced genetic testing methods, including next-generation sequencing, to identify a homozygous missense variant in the CD70 gene—meaning the patient inherited two copies of the genetic defect.

Once CD70 deficiency was confirmed, the patient underwent hematopoietic stem cell transplantation (HSCT), a procedure in which blood-forming stem cells are transplanted to rebuild the immune system. The transplant successfully treated the underlying CD70 deficiency.

Following HSCT, the patient's diabetes management improved notably. Median HbA1c—a measure of average blood sugar over time—decreased from 8.1% to 6.5%, indicating better glycemic control. Daily insulin requirements also fell from 0.85 to 0.62 units per kilogram of body weight, suggesting that the patient's own pancreatic function was preserved or partially restored.

This case expands our understanding of what can cause type 1 diabetes. While the vast majority of type 1 diabetes cases follow the classic autoimmune pattern, rare genetic defects in immune regulation—like CD70 deficiency—may contribute to severe, early-onset forms of the disease in some individuals.

The finding suggests that patients with unusually severe diabetes onset, especially those with other unexplained immune or systemic symptoms, may benefit from genetic investigation to identify rare underlying causes. Although CD70 deficiency is extremely rare, recognizing this link could help guide treatment decisions and offers hope that addressing the underlying immune defect may improve diabetes management.

Source: Pediatric diabetes. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.